Skip to main content
Not Found
Digital Seminar

Anti-Obesity Medications (AOMs) for Short and Long-Term Pharmacotherapy Treatment

Pamela Moye, PharmD, BCPS
2 Hours
Audio and Video
Mar 21, 2024
Product Code:
Media Type:
Digital Seminar


Obesity is a complex and multifaceted condition that affects individuals across all age groups, races, and socioeconomic backgrounds, with far-reaching consequences for their health and well-being. It is a prevalent global health issue affecting approximately half the world’s population. A shared mission among healthcare professionals is to equip themselves with the knowledge and skills to address this critical issue effectively. The pharmacotherapy management of obesity is not just about prescribing medications; it is about transforming lives, improving patient outcomes, and helping individuals regain control over their health and quality of life. Currently, the Federal Drug Administration (FDA) has approved nine anti-obesity medications (AOMs) for the short and long-term treatment of obesity. AOMs are recommended with lifestyle change for the therapy of overweight and obesity, following a similar methodology to other chronic disorders.

Pamela Moye, PharmD, BCPS, will breakdown the various facets of obesity management, from understanding the root causes and the epidemiological context to exploring the latest pharmacological interventions. This engaging session will also provide you with insights into practical approaches to develop patient-centered treatment plans, empower patients with the knowledge they need to make informed decisions about their health and promote long-term adherence. There will be an exploration of case studies that challenge decision-making skills and enrich clinical expertise.


Planning Committee Disclosure - No relevant relationships

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.

* Credit Note - **

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after passing the online post-test (80% passing score) and completing the evaluation). Instructional methods will include PowerPoint, didactic lecture, and others.

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Program content is reviewed periodically per accrediting board rules for currency and appropriateness for credit. Credit approvals are subject to change. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. 
For other credit inquiries not specified below, please contact or 800-844-8260 before purchase.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

For Planning Committee disclosures, please see the statement above.  For speaker disclosures, please see the faculty biography.

* Credit Note - ---

Earn up to 2.0 CE hours. Please see below, for more details, as credit amounts vary by state and profession. 

Nurses - Pharmacology Nurse Practitioners

This self-study program offers 120 instructional minutes of pharmacology content which is designed to qualify for 2.0 contact hours toward your pharmacology requirement. 

Nurses - Nurses, Nurse Practitioners, and Clinical Nurse Specialists - ANCC

PESI, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing these self-study materials will earn 2.0 contact hours. Expires: 01/17/2027.

Nurses - California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 2.0 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Nurses - Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 2.0 self-study contact hours.

CE Broker

Nurses - Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 2.0 self-study contact hours. Please email with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.

Physicians - Physicians

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. This activity was originally recorded on 03/21/2024. It was last reviewed on 01/17/2024 and is valid until 01/17/2027.


Physicians should only claim credit commensurate with the extent of their participation in the activity. You are required to successfully complete and submit a post-test prior to receiving a certificate of completion.

Physicians Assistants - Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 2.0 hours for completing this self-study program. This activity was originally recorded on 03/21/2024. It was last reviewed on 01/17/2024 and is valid until 01/17/2027


PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™.

Other Professions

This self-study activity qualifies for 2.0 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



Pamela Moye, PharmD, BCPS's Profile

Pamela Moye, PharmD, BCPS Related seminars and products

Pamela Moye, PharmD, BCPS, is a seasoned and dedicated professional with experience in pharmacy education and patient care. As a board-certified pharmacotherapy specialist, she has been at the forefront of imparting knowledge and skills to diverse learners, including pharmacy and medical students, residents, and licensed healthcare professionals. Dr. Moye’s expertise lies in guiding her students and fellow professionals in evidence-based pharmacotherapy tailored to individual patients’ needs, clinical presentations, laboratory data, and co-existing medical conditions.

Dr. Moye has excelled in her role as an educator and as a liaison between healthcare providers and patients. She has played a pivotal role in ensuring healthcare providers communicate effectively with their patients, helping them understand and adhere to the prescribed medications. Among her many areas of expertise, Dr. Moye has a particular interest in using medications to treat obesity. Her research and teaching in this field aim to shed light on evidence-based pharmacotherapy options for obese individuals, offering hope and solutions to improve their health and well-being.

Dr. Moye’s passion for education runs deep, and it is intricately intertwined with her dedication to making a positive impact on society. Her commitment to lifelong learning and continuous improvement drives her teaching, practice, and research. She believes the key to improving patients outcomes and advancing pharmacy practice lies in empowering others through education and fostering a culture of lifelong learning.

Speaker Disclosures:
Financial: Pamela Moye has an employment relationship with Mercer University College of Pharmacy. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Pamela Moye serves as the chair of the American Association of Colleges of Pharmacy. She is a member of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas, the National Pharmaceutical Association, American Academy of HIV Medicine, and the American College of Clinical Pharmacy.


Additional Info


Visit our FAQ page at or contact us at

Access Period for Live Webcast

For live CE credit, you must watch the live webcast in its entirety at its scheduled time and complete the CE quiz and evaluation within one week. You will have access for 90 days after the program for review.

Webcast Schedule

Please note: There will be a lunch and two 15-minute breaks; one in the morning and one in the afternoon. Lunch and break times will be announced by the speaker and at their discretion. A more detailed schedule is available upon request.


  1. Review the underlying pathophysiology of obesity and metabolic adaptations to weight loss.
  2. Identify the pharmacotherapy options available for obesity management, including FDA-approved medications, their mechanisms of action, and their efficacy.
  3. Explain the indications, contraindications, and precautions associated with various obesity medications.
  4. Recognize potential side effects and adverse reactions of obesity medications and develop strategies for managing them.
  5. Implement monitoring and follow-up strategies to assess the effectiveness of pharmacotherapy and address non-responder and relapse issues.
  6. Apply the most recent evidence-based guidelines to develop individualized patient treatment plans, considering patient-specific factors and goals.


FDA Approved Obesity Pharmacotherapy Options
  • Orlistat
  • Phentermine
  • Phentermine and topiramate extended release
  • Byproprion and naltrexone extended release
  • Liraglutide
  • Semaglutide
  • Setmelanotide
  • Tirzepatide
Mechanism of action and efficacy
Indications, contraindications, and precautions
Potential side effects and adverse reactions
Medication safety and monitoring

Individualized Treatment Plans
  • Tailoring pharmacotherapy to patient-specific factors
  • Dosing strategies and titration
  • monitoring and follow-up
  • Addressing non-responder and relapse issues
Case Study Reviews
  • Review patient cases and scenarios
  • Discussion of treatment decisions and outcomes


Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

Please wait ...

Back to Top